Key terms
About LEGN
Legend Biotech Corp. is a clinical-stage biopharmaceutical company, which engages in the discovery, development, manufacturing, and commercialization of novel therapies for oncology and other indications. The firm develops advanced cell therapies across a diverse array of technology platforms, including autologous and allogeneic chimeric antigen receptor T-cell, gamma-delta T cell and natural killer cell-based immunotherapy. It operates through the following geographical segments: United States of America, China, and Other. The company was founded in 2014 and is headquartered in Somerset, NJ.
Sector
Industry
Employees
Founded
Website
Key stock statistics
1-day range
52-week range
Market cap
P/E ratio
Next earnings date
Dividend yield
Ex-dividend date
Dividend pay date
Key terms
Ad Feedback
Smart score
Latest LEGN news
Today
6:20am ET
Analysts Offer Insights on Healthcare Companies: Legend Biotech (LEGN), Astria Therapeutics (ATXS) and Aslan Pharmaceuticals (ASLN)
Yesterday
5:15pm ET
Hold Rating on Legend Biotech Amidst Approval of Carvykti and Commercial Manufacturing Challenges
Yesterday
1:57pm ET
European Approval for Legend Biotech’s Myeloma Treatment
Apr 17
9:00am ET
Wall Street Analysts Are Bullish on Top Healthcare Picks
Apr 17
7:21am ET
Analysts’ Top Healthcare Picks: Evolent Health (EVH), Nurix Therapeutics (NRIX)
Apr 17
7:20am ET
Scotiabank upgrades Legend Biotech on attractive entry point
Apr 17
6:41am ET
Legend Biotech upgraded to Outperform from Sector Perform at Scotiabank
Apr 16
8:21pm ET
Analysts Are Bullish on These Healthcare Stocks: Legend Biotech (LEGN), Genmab (GMAB)
Apr 16
8:18pm ET
Buy Rating Affirmed for Legend Biotech Amidst Anticipated Growth and Expanded Carvykti Use
Apr 16
8:06pm ET
Maintaining Buy Rating on Legend Biotech Amidst Expected Growth and Strong Market Demand for Carvykti
Apr 16
11:55am ET
Buy Rating Affirmed for Legend Biotech Amidst Growth Prospects and CARVYKTI’s Market Expansion
Apr 16
11:49am ET
J&J report ‘not alarming’ for Legend Biotech, says H.C. Wainwright
Apr 16
7:57am ET
Legend Biotech Reports Preliminary Sales Surge
Apr 08
9:50pm ET
Analysts Offer Insights on Healthcare Companies: Pacira Pharmaceuticals (PCRX), Legend Biotech (LEGN) and Intellia Therapeutics (NTLA)
Apr 08
7:50pm ET
Analysts Are Bullish on Top Healthcare Stocks: Syndax Pharmaceuticals (SNDX), Legend Biotech (LEGN)
Apr 08
8:25am ET
Buy Rating Affirmed for Legend Biotech Following FDA Approval and Positive Growth Outlook
Apr 08
7:58am ET
Legend Biotech’s CARVYKTI® Revolutionizes Multiple Myeloma Treatment
Apr 08
7:20am ET
Analysts Conflicted on These Healthcare Names: Legend Biotech (LEGN), Intuitive Surgical (ISRG) and Disc Medicine (IRON)
Apr 08
6:37am ET
Legend Biotech (LEGN) Gets a Buy from Piper Sandler
Apr 08
6:22am ET
Wall Street Analysts Are Bullish on Top Healthcare Picks
Apr 08
4:35am ET
Balancing Milestones and Market Challenges: A Hold Rating for Legend Biotech
Apr 07
2:55pm ET
Buy Rating on Legend Biotech: FDA Approval and Market Potential Bolster Carvykti’s Outlook
Apr 07
6:25am ET
Legend’s CARVYKTI approved by FDA for second-line treatment of multiple myeloma
Apr 03
6:49am ET
Cantor starts Legend Biotech at Overweight on Carvykti expansion
Apr 03
6:12am ET
Legend Biotech initiated with an Overweight at Cantor Fitzgerald
Apr 02
7:10am ET
Wall Street Analysts Are Bullish on Top Healthcare Picks
Apr 02
7:00am ET
Analysts Are Bullish on These Healthcare Stocks: Shockwave Medical (SWAV), Veeva Systems (VEEV)
Apr 01
6:20am ET
Analysts Offer Insights on Healthcare Companies: Daré Bioscience (DARE), Legend Biotech (LEGN) and Imunon (IMNN)
Mar 29
8:57am ET
Legend Biotech Boosts Drug Production with Novartis
Mar 24
5:04am ET
Analysts Offer Insights on Healthcare Companies: AbbVie (ABBV) and Legend Biotech (LEGN)
Mar 19
7:59am ET
Legend Biotech files automatic mixed securities shelf
No recent press releases are available for LEGN
LEGN Financials
Key terms
Ad Feedback
LEGN Forecasts
analyst rating
- buy
- hold
- sell
1-year stock price forecast
LEGN Competitors
$ Market cap
P/E ratio
$ Price
1d change
52-week range
